Tanning as an addictive behavior: A literature review

Photodermatology Photoimmunology and Photomedicine

Volumn 25, Issue 1, 2009, Pages 12-19

  Nolan, Bridgit V ^a   Taylor, Sarah L ^a   Liguori, Anthony ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; Tanning practices; Ultraviolet radiation

Indexed keywords

BETA ENDORPHIN; CORTICOTROPIN; ENDORPHIN; PROTEIN P53;

ADDICTION; ANNOYANCE; CLINICAL TRIAL; COGNITION; CRITERION VARIABLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GUILT; HEALTH HAZARD; HUMAN; IMPULSE CONTROL DISORDER; OBSESSIVE COMPULSIVE DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL MODEL; REVIEW; SELF CONCEPT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL LEARNING; SUNBATHING; ULTRAVIOLET RADIATION; WITHDRAWAL SYNDROME;

BEHAVIOR, ADDICTIVE; HUMANS; MODELS, BIOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; SUNBATHING;

EID: 58149523184     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2009.00392.x     Document Type: Review

References (76)

1. Zeller S, Lazovich D, Forster J, Widome R. Do adolescent indoor tanners exhibit dependency? J Am Acad Dermatol 2006; 54: 589-596.
2. MacNeal RJ, Dinulos JG. Update on sun protection and tanning in children. Curr Opin Pediatr 2007; 19: 425-429.
3. Swerdlow AJ, Weinstock MA. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998; 38: 89-98.
4. Council on Scientific Affairs. Harmful effects of ultraviolet radiation. JAMA 1989; 262: 380-384.
5. Poorsattar SP, Hornung RL. UV light abuse and high-risk tanning behavior among undergraduate college students. J Am Acad Dermatol 2007; 56: 375-379.
6. Knight JM, Kirincich AN, Farmer ER, Hood AF. Awareness of the risks of tanning lamps does not influence behavior among college students. Arch Dermatol 2002; 138: 1311-1315.
7. Feldman SR, Liguori A, Kucenic M, et al. Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol 2004; 51: 45-51.
8. Kaur M, Liguori A, Lang W, Rapp SR, Fleischer AB Jr., Feldman SR. Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol 2006; 54: 709-711.
9. Kaur M, Liguori A, Fleischer AB Jr., Feldman SR. Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. J Am Acad Dermatol 2006; 54: 919-920.
10. Wintzen M, Ostijn DM, Polderman MC, le Cessie S, Burbach JP, Vermeer BJ. Total body exposure to ultraviolet radiation does not influence plasma levels of immunoreactive beta-endorphin in man. Photodermatol Photoimmunol Photomed 2001; 17: 256-260.
11. Gambichler T, Bader A, Vojvodic M, Avermaete A, Schenk M, Altmeyer P, Hoffmann K. Plasma levels of opioid peptides after sunbed exposures. Br J Dermatol 2002 147: 1207-1211.
12. Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell 2007; 128: 853-864.
13. Kaur M, Feldman SR, Liguori A, Fleischer AB Jr. Indoor tanning relieves pain. Photodermatol Photoimmunol Photomed 2005; 21: 278.
14. American Psychiatric Association, Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association, Task Force on DSM-IV, 2000.
15. Warthan MM, Uchida T, Wagner RF Jr. UV light tanning as a type of substance-related disorder. Arch Dermatol 2005; 141: 963-966.
16. Brandon TH, Herzog TA, Irvin JE, Gwaltney CJ. Cognitive and social learning models of drug dependence: Implications for the assessment of tobacco dependence in adolescents. Addiction 2004; 99(Suppl. 1): 51-77.
17. Carter BL, Tiffany ST. Meta-analysis of cue-reactivity in addiction research. Addiction 1999; 94: 327-340.
18. Golan DE. In: Golan David E., editor-in-chief
19. Golan DE., Tashjian Armen H., deputy editor Golan DE., Tashjian Armen H., Armstrong Ehrin J., et al., eds. Principles of pharmacology: The pathophysiologic basis of drug therapy. Baltimore: Lippincott Williams & Wilkins, 2005.
20. Sadock BJ, 1927, Kaplan and Sadock's synopsis of psychiatry. Kaplan & Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry. Philadelphia, PA: Lippincott Williams & Wilkins, 2003.
21. Schuckit MA. Drug and alcohol abuse: A clinical guide to diagnosis and treatment. New York: Kluwer Academic/Plenum Publishers, 2000.
22. Donovan DM, Dennis M. Assessment of addictive behaviors. New York: Guilford Press, 2005.
23. Hunter-Yates J, Dufresne RG Jr., Phillips KA. Tanning in body dysmorphic disorder. J Am Acad Dematol 2007; 56(Suppl.): S107-S109.
24. Phillips KA, Dufresne RG Jr., Wiklel CS, Vittorio CC. Rate of body dysmorphic disorder in dermatology patients. J Am Acad Dermatol 2000; 42(3): 436-441.
25. Dufresne RG, Phillips KA, Vittorio CC, Wilkel CS. A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg 2001; 27: 457-462.
26. Jorgensen L, Castle D, Roberts C, Groth-Marnat G. A clinical validation of the dysmorphic concern questionnaire. Aust NZ J Psychiatry 2001; 35: 124-128.
27. Grabill K, Merlo L, Kule D, et al. Assessment of obsessive-compulsive disorder: A review. J Anxiety Disord 2008; 22: 1-7 Epub February 3, 2007.
28. Saeed SA, Bruce TJ. Seasonal affective disorders. Am Fam Physician 1998; 57: 1340-6-1351-2.
29. Hillhouse J, Stapleton J, Turrisi R. Association of frequent indoor UV tanning with seasonal affective disorder. Arch Dermatol 2005; 151: 1465.
30. World Health Organization. International statistical classification of diseases and health related problems ICD-10, Vol. 2: Instruction Manual (2nd edn, 10th revision). Geneva, Switzerland: World Health Organization, 2004.
31. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905-1907.
32. Smith GT, Goldman MS, Greenbaum PE, Christiansen BA. Expectancy for social facilitation from drinking: The divergent paths of high-expectancy and low-expectancy adolescents. J Abnorm Psychol 1995; 104: 32-40.
33. Brown SA, Christiansen BA, Goldman MS. The alcohol expectancy questionnaire: An instrument for the assessment of adolescent and adult alcohol expectancies. J Stud Alcohol 1987; 48: 483-491.
34. Boudreaux E, Carmack CL, Searinci IC, Brantley PJ. Predicting smoking stage of change among a sample of low socioeconomic status, primary care outpatients: Replication and extension using decisional balance and self-efficacy theories. Int J Behav Med 1998; 5: 148-165.
35. Prochaska JO, DiClemente CC. Self change processes, self efficacy and decisional balance across five stages of smoking cessation. Prog Clin Biol Res 1984; 156: 131-140.
36. Prochaska JO, DiClemente CC, Velicer WF, Ginpil S, Norcross JC. Predicting change in smoking status for self-changers. Addict Behav 1985; 10: 395-406.
37. Beasley TM, Kittel BS. Factors that influence health risk behaviors among tanning salon patrons. Eval Health Prof 1997; 20: 371-388.
38. Noff-Burg S, Mosher CE. Predictors of tanning salon use: Behavioral alternatives for enhancing appearance, relaxing and socializing. J Health Psychol 2006; 11: 511-518.
39. McClernon FJ, Hiott FB, Liu J, Salley AN, Behm FM, Rose JE. Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: Results of a preliminary functional magnetic resonance imaging study. Addict Biol 2007; 12: 503-512.
40. Carter BL, Robinson JD, Lam CY, et al. A psychometric evaluation of cigarette stimuli used in a cue reactivity study. Nicotine Tob Res 2006; 8: 361-369.
41. Saladin ME, Brady KT, Graap K, Rothbaum BO. A preliminary report on the use of virtual reality technology to elicit craving and cue reactivity in cocaine dependent individuals. Addict Behav 2006; 31: 1881-1894.
42. Conklin CA. Environments as cues to smoke: Implications for human extinction-based research and treatment. Exp Clin Psychopharmacol 2006; 14: 12-19.
43. Upadhyaya HP, Drobes DJ, Wang W. Reactivity to in vivo smoking cues in older adolescent cigarette smokers. Nicotine Tob Res 2006; 8: 135-140.
44. Lee JH, Lim Y, Wiederhold BK, Graham SJ. A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments. Appl Psychophysiol Biofeedback 2005; 30: 195-204.
45. Dom G, Sabbe B, Hulstijn W, van den BW. Substance use disorders and the orbitofrontal cortex: Systematic review of behavioural decision-making and neuroimaging studies. Br J Psychiatry 2005; 187: 209-220.
46. David SP, Munafo MR, Johansen-Berg H, et al. Ventral striatum/nucleus accumbens activation to smoking-related pictorial cues in smokers and nonsmokers: A functional magnetic resonance imaging study. Biol Psychiatry 2005; 58: 488-494.
47. McClernon FJ, Gilbert DG. Human functional neuroimaging in nicotine and tobacco research: Basics, background, and beyond. Nicotine Tob Res 2004; 6: 941-959.
48. Chiamulera C. Cue reactivity in nicotine and tobacco dependence: A "multiple-action"model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli. Brain Res Brain Res Rev 2005; 48: 74-97.
49. Colby SM, Rohsenow DJ, Monti PM, et al. Effects of tobacco deprivation on alcohol cue reactivity and drinking among young adults. Addict Behav 2004; 29: 879-892.
50. Upadhyaya HP, Drobes DJ, Thomas SE. Reactivity to smoking cues in adolescent cigarette smokers. Addict Behav 2004; 29: 849-856.
51. Shadel WG, Niaura R, Abrams DB. Effect of different cue stimulus delivery channels on craving reactivity: Comparing in vivo and video cues in regular cigarette smokers. J Behav Ther Exp Psychiatry 2001; 32: 203-209.
52. Shadel WG, Niaura R, Abrams DB, et al. Scripted imagery manipulations and smoking cue reactivity in a clinical sample of self-quitters. Exp Clin Psychopharmacol 1998; 6: 179-186.
53. Niaura R, Shadel WG, Abrams DB, Monti PM, Rohsenow DJ, Sirota A. Individual differences in cue reactivity among smokers trying to quit: effects of gender and cue type. Addict Behav 1998; 23: 209-224.
54. Volkow ND, Wang GJ, Ma Y, et al. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003; 23: 11461-11468.
55. Volkow ND, Wang GJ, Ma Y, et al. Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects. Neuroimage 2006; 32: 1782-1792.
56. Magee KH, Poorsattar S, Seidel KD, Hornung RL. Tanning device usage: what are parents thinking? Pediatr Dermatol 2007; 24: 216-221.
57. Lazovich D, Forster J, Sorensen G, et al. Characteristics associated with use or intention to use indoor tanning among adolescents. Arch Pediatr Adolesc Med 2004; 158: 918-924.
58. Ezzedine K, Malvy D, Mauger E, et al. Artificial and natural ultraviolet radiation exposure: Beliefs and behaviour of 7200 French adults. J Eur Acad Dermatol Venereol 2008; 22: 186-194.
59. Volkow ND, Fowler JS, Wang GJ. The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies. Neuropharmacology 2004; 47(Suppl. 1): 3-13.
60. Ashburner J, Csernansky JG, Davatzikos C, Fox NC, Frisoni GB, Thompson PM. Computer-assisted imaging to assess brain structure in healthy and diseased brains. Lancet Neurol 2003; 2: 79-88.
61. Gatley SJ, Volkow ND. Addiction and imaging of the living human brain. Drug Alcohol Depend 1998; 51: 97-108.
62. Volkow ND, Fowler JS. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb Cortex 2000; 10: 318-325.
63. Volkow ND, Ding YS, Fowler JS, Wang GJ. Cocaine addiction: Hypothesis derived from imaging studies with PET. J Addict Dis 1996; 15: 55-71.
64. Fowler JS, Volkow ND, Kassed CA, Chang L. Imaging the addicted human brain. Sci Pract Perspect 2007; 3: 4-16.
65. Sinha R, Lacadie C, Skudlarski P, et al. Neural activity associated with stress-induced cocaine craving: A functional magnetic resonance imaging study. Psychopharmacology (Berlin) 2005; 183: 171-180.
66. Gorelick DA, Kim YK, Bencherif B, et al. Imaging brain mu-opioid receptors in abstinent cocaine users: Time course and relation to cocaine craving. Biol Psychiatry 2005; 57: 1573-1582.
67. Wexler BE, Gottschalk CH, Fulbright RK, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001; 158: 86-95.
68. Pfefferbaum A, Sullivan EV, Rosenbloom MJ, Mathalon DH, Lim KO. A controlled study of cortical gray matter and ventricular changes in alcoholic men over a 5-year interval. Arch Gen Psychiatry 1998; 55: 905-912.
69. Pfefferbaum A, Sullivan EV, Mathalon DH, Shear PK, Rosenbloom MJ, Lim KO. Longitudinal changes in magnetic resonance imaging brain volumes in abstinent and relapsed alcoholics. Alcohol Clin Exp Res 1995; 19: 1177-1191.
70. Pfefferbaum A, Lim KO, Zipursky RB, et al. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: A quantitative MRI study. Alcohol Clin Exp Res 1992; 16: 1078-1089.
71. Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-6036.
72. Chang L, Alicata D, Ernst T, Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007; 102(Suppl. 1): 16-32.
73. London ED, Bonson KR, Ernst M, Grant S. Brain imaging studies of cocaine abuse: Implications for medication development. Crit Rev Neurobiol 1999; 13: 227-242.
74. Mena JC, Cuellar H, Vargas D, Riascos R. PET and SPECT in drug and substance abuse. Top Magn Reson Imaging 2005; 16: 253-256.
75. Gatley SJ, Volkow ND, Wang GJ, et al. PET imaging in clinical drug abuse research. Curr Pharm Des 2005; 11: 3203-3219.
76. Wong DF, Maini A, Rousset OG, Brasic JR. Positron emission tomography-a tool for identifying the effects of alcohol dependence on the brain. Alcohol Res Health 2003; 27: 161-173.